Armed with $54M, Bob Langer spinout preps for 2024 commercial launch

Ten years after it launched with technology from the labs of MIT professor Bob Langer and Brigham and Women’s Hospital’s Jeffrey Karp, a French-Boston biotech is preparing to launch its first product with the help of $54 million.